Veklury 100 mg/1
remdesivir · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Gilead Sciences, Inc.
Veklury (remdesivir) is an intravenous injection used to treat COVID-19 by inhibiting the virus's ability to replicate. It belongs to a class of antiviral drugs called nucleotide analog RNA polymerase inhibitors and is administered by a healthcare provider.
Key Facts
- Brand Name
- Veklury
- Generic Name
- remdesivir
- NDC Code (Product)
61958-2901- Manufacturer
- Gilead Sciences, Inc.
- Strength
- 100 mg/1
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA214787
- Drug Class
- SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC]
- Marketing Start
- 11/01/2020
Recall History
No Recall HistoryFrequently Asked Questions
What is Veklury used for?
Veklury (remdesivir) is an intravenous injection used to treat COVID-19 by inhibiting the virus's ability to replicate. It belongs to a class of antiviral drugs called nucleotide analog RNA polymerase inhibitors and is administered by a healthcare provider.
Is Veklury a controlled substance?
Veklury is not classified as a controlled substance by the DEA.
What is the generic name for Veklury?
The generic name for Veklury is remdesivir. There are no other listed brand versions of remdesivir.
What is the NDC code for Veklury 100 mg/1?
The NDC (National Drug Code) for Veklury 100 mg/1 is 61958-2901, listed by Gilead Sciences, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)